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Earlier reports (1-5) have described  the partial purification and some of the proper- 
ties of choleragen, an antigenic, diarrheagenic protein enterotoxin elaborated by certain 
strains of cholera vibrios. Although the biological activity of choleragen  in promoting 
fluid loss via the intestinal tract is usually demonstrated in experimental animal sys- 
tems, such as the infant rabbit or the ligated intestinal loop of the adult rabbit, a 
choleragen-containing culture filtrate has been reported to produce eholeraic  mani- 
festations in human subjects (6)  thus confirming  its activity and pertinence to the 
human disease. In addition, similar biologic activities have been found in filtrates of the 
liquid stool of cholera patients (7, 8). Recently, rises in titer of serum antibody capable 
of neutralizing one of the activities associated with choleragen,  its skin reactivity (9), 
have been reported to occur in cholera convalescents (10). The fact that choleragen  is 
immunogenle (11), as well as antigenic,  is of considerable  interest since currently used 
conventional cholera vaccines offer only limited protection against the disease in man 
(12).  Although  partially purified preparations have been demonstrated  to  contain 
potent vascular permeability activity (9), the precise mode of action of choleragen  in 
producing eholeraie diarrhea has yet to be defined. Moreover, the question of whether 
choleragen  is itself a permeability factor or whether the permeability enhancing ac- 
tivity is associated with a contaminant has not been resolved. 
The accumulation of data relating to the chemical composition and structure 
of choleragen, its mode of action, and its immunogenic potential has been im- 
peded by the lack of sufficient amounts of material of suitable purity to carry 
out these studies. Accordingly, we have attempted to escalate the laboratory 
scale  production  of  choleragen  and  to  develop methods  for  its  purification. 
During this investigation, which relied on double diffusion immune precipitation 
techniques for recognition of choleragen antigen,  a  new moiety was detected. 
This protein is apparently identical with choleragen antigenically,  but differs 
in  size and  charge.  We propose that  this  substance,  which  has little,  if any, 
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choleragenic or permeability activity, be called "choleragenoid". It may prove 
useful as a nontoxic immunogen. In addition, it was  found  that  highly purified 
choleragen retains its permeability enhancing activity, thus  offering additional 
evidence  that  choleragenicity  and  permeability  enhancement  are  associated 
phenomena. 
Materials and Methods 
Choleragen was produced in 9 or 10 liter volumes of syncase medium (4) in a Virtis Model 
40-100  fermenter of 12  liter capacity inoculated with approximately  105 viable cells/ml of 
Vibrio cholerae strain 569 B  Inaba. Antifoam A  (Dow Coming Corp., Midland, Mich.) was 
added at 8 hr. After incubation at 30°C for 20-24 hr with vigorous aeration (7.6 liter/rain.) 
and stirring by means of a magnetic agitator at 50(0700 rpm, the temperature was raised to 
37°C and the bulk of the organisms killed by the addition of 0.05 to 0.1% beta-proplolactone 
(BPL,  Betaprone,  Fellows-Testagar,  Div. Fellows Medical Mfg.  Co.,  Detroit,  Mich.)  and 
further incubation for 2 hr. The ceils were removed by continuous flow centrifugation at 16,000 
rpm and a flow rate of approximately 100 ml/min, in a Sorvali RC2B refrigerated centrifuge 
fitted with  the  Szent-Gyorgi and  Blum  system.  The  choleragen  and  other proteins  were 
precipitated by the addition of ammonium sulfate (70 g/100 ml), which also served effectively 
to kill any residual viable vibrios. The precipitate was harvested, after standing overnight at 
room temperature, by continuous flow centrifugation using a "basket" centrifuge (Virtis Co., 
Inc., Gardiner, N.Y.) with fine grade filter paper. A second precipitate, which formed in the 
supernate  on further standing for a  day, was harvested by conventional filtration through 
paper and added to the first. After dialysis in the cold vs. distilled water, the preparation was 
lyophili~.ed. When four such preparations had been accumulated, the powders were pooled by 
suspension in approximately 200  ml of 0.01  st PO4 buffer, pH 7.5,  and added  to i  kg wet 
weight of diethylaminoethyl cellulose  (DEAEC, Whatman microgranular DE 52) which had 
previously been equilibrated with the same buffer. After stirring for 1 hr, the excess fluid was 
removed by filtration through a sintered glass funnel and choleragen was einted by washing 
with 0.1  xf PO4 buffer, pH 6.0.  This procedure leaves a  considerable amount  of unrelated 
protein  and  brown pigment  absorbed  to  the  DEAEC  (which  was  then  recycled for  sub- 
sequent use).  At first,  the choleragen-containing  eluate was  concentrated  by (NH4)~ SO4 
precipitation,  dialysis, and  lyophilization. In later experiments it was  concentrated  by ni- 
trafiltration  through  Diaflo  UM-10  membranes  (Amicon  Corp.,  Lexington,  Mass.).  The 
concentrate was then subjected to gel filtration on a 5 X  125 cm column of Agarose (Rio-Gel 
A-5m, 200-400 mesh, Bio-Rad Laboratories, Richmond, Calif.) using Tris-EDTA buffer pH 
7.5  (0.05  ~  tris-hydroxymethylaminomethane,  0.001  ~  ethylenediaminetetraacetic  add 
disodium salt, 0.003 st NaNs, 0.2 ~(NaC1)  as eluant at a flow rate of approximately 60 ml/hr. 
The choleragen-containing fractions, identified by Ouchterlony agar gel double diffusion  tests 
with specific anti-choleragen rabbit serum, in a late appearing component as indicated by its 
absorbance at 280 m/~, were pooled, concentrated by ultrafiltration, and rechromatographed 
through two 2.5 X  90 cm columns of Sephadex G-75 (Pharmacia Fine Chemicals, Piseataway, 
N.J.) connected in series.  In the latter instance, 0.4 st ammonium formate containing 0.003 
st NaNa was employed as eluting buffer at a flow rate of 20 mlfur. Fractions containing choler- 
agen antigen were again identified by Ouchterlony precipitation, pooled, and concentrated by 
ultrafiltration. Gel filtration columns were calibrated periodically by determination of elution 
volume of known molecular weight markers, according to methodology adapted from Andrews 
(13). 
Immunoelectrophoresis with LKB apparatus  (LKB Instruments Inc., Rockvilie, Md.) was 
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5 td of antigen preparation at a concentration of 10 mg/ml. Current was set at 50 ma and 250 v 
for 1 hr, afterwhich 0.1 ml of antiserum was added to the trough. Results were photographed 
after incubation overnight in a  humid  chamber at  room  temperature.  Disc eleetrophoresis 
using Canalco equipment (Canal Industrial Corp., Rockville, Md.) was performed according 
to the procedure of Ornstein and Davis (14).  Protein concentrations were determined by the 
biuret colorimetric procedure as well as by optical density readings at 280 ~  in a Beckman 
DU spectrophotometer employing an extinction coefficient (1% solution) of 10.5.  Ultracen- 
trifugation studies were conducted in a  Spinco Model E  ultracentrifuge in the standard cell 
or in double sector cells. 
Tests for biologic or immunologic activity, namely, cholerageuicity in suckling  rabbits, 
¢nterosorptive effects in ligated intestinal loops of  adult  rabbits,  skin  reactivity in  adult 
rabbits, and Ouchterlony precipitin tests, were performed essentially as described in earlier 
publications (see above). Variations considered significant were the introduction of a  system 
of scoring choleragenicity in infant rabbits, which makes interpretations of  activity more 
quantitative, and a  micro-Ouchteriony technique for assay of smaller amounts of antigen or 
antibody. As described previously, groups of four gastrically lavaged infant rabbits approxi- 
mately 10 days old were fed dilutions of test material in 1 ml of 2% K~T-IPO~, 2% Na2HPO4. 
After 16--18 hr, surviving animals were sacrificed. The relative amount of fluid in the intestinal 
tract at autopsy was observed and scored on a 0 to 4 +  basis. If the animals had overt diar- 
rhea, this was also scored on a  relative 0  to 4  +  basis according to the proportion of the 
distance from anus to neck, on the ventral surface, which was stained or wet with liquid 
feces.  1 Animals found dead with  excessive intestinal fluid  and/or  diarrhea were  given an 
additional two points; if moribund, one point. The total score for each animal was obtained 
and a  mean determined for the dosage group. Thus, if all four animals succumbed, the mean 
score for that group was 10. If no animals died, but three out of four had 2 +  diarrhea, one 
had none, and all had 4  +  excessive fluid, the mean score would be 5.5 derived as follows: 
(score of fluid)  +  (score of diarrhea) 
(4+4+4+4)+(2+2+2+0) 
=  5.5 
(4)  No. of animals 
The  micro-Ouchterlony  technique  employed  "immuno-plates"  (Hyland  Laboratories, 
Los Angeles, Calif.) which were filled, in this laboratory, with 2.5 ml of melted and cooled 0.5% 
Ionagar No. 2  (Oxoid) in 0.85% saline containing 1: i0,000 merthiolate. Wells were cut with 
a  specially designed and constructed stainless steel gel cutter and the agsr was removed by 
suction through a sawed-off hypodermic needle. Thewellswere 2ram in diameter; the distance 
from the edges of the perimeter wells to the edges of the central wells was 2.5 mm; four patterns 
of six peripheral wells and a central well were made simultaneously in each plate; and the wells 
were filled with 0.004 ml by means of a  micropipette. Distinct precipitin bands appeared as 
early as 1 hr but were generally observed after overnight standing at room temperature in a 
sealed  polyethylen  e  bag. 
A radial diffusion technique was also employed for prccipitin assay of submicrogram quanti- 
ties of choleragen and choleragenoid. The technique, an adaptation of the method of Fahey 
and McKelvey  (15), was similar to that described above, except that antiserum was incor- 
porated in the agar, at 0.2 ml per 10 ml, and a more appropriate linear pattern was used. These 
assays were performed in quadruplicate and the diameters of the zones of precipitation were 
determined with the aid of a stereoscopic dissecting microscope fitted with an optical reticle. 
The amount of serum incorporated in the agar menstruum was determined by prior titration 
to attain the highest sensitivity consistent with optimal visibility of the precipitin zone. 
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Antisera to partially purified choleragen were prepared as described previously (11) and 
treated  with living vibrios of the homologous strain to remove anti-vibrio antibodies. The 
reference antiserum pool formed a visible precipitin band with undiluted culture filtrate in 
the macro-Ouchterlony  test at a dilution of 1:16 to 1: 32. When highly purified choleragen and 
choleragenoid were obtained, additional rabbits were immunized in the same manner, with 
the exception that only 2 mg of antigen were used per animal instead of 5. Absorption of the 
latter sera was not required. 
RESULTS 
Characteristics  of Fermenter  Cultures  and Fermenter  Culture  Filtrales.--The 
viable coant of fermenter cultures ranged between 1 X  10  ~° and 2 X  10  l° vibrios 
per ml prior  to the addition  of BPL.  Filtrates  sterilized by passage through 
Millipore membranes (Millipore Corp., Bedford, Mass.), prepared before addi- 
tion  of  BPL,  caused  marked  choleraic  manifestations  (a  mean  choleragenic 
score of 5) at a  dilution of 1:71 in groups of gastrically lavaged infant rabbits 
administered 1.0 ml per os into the stomach (Fig. 1). After the addition of BPL, 
there appeared to be some reduction of the choleragenic activity as indicated by 
somewhat more erratic bioassay results. In a  representative assay (Fig.  1), the 
reduction of activity was found to be approximately 2.5-fold, so that a  1:28.5 
dilution of BPL-treated filtrate was required to produce the same effect in infant 
rabbits. Treatment with BPL, however, had no detectable effect on the precipi- 
tating antigen content of the filtrates: a visible precipitin band was formed with 
0.05 ml anti-choleragen serum when 0.1 ml of 1:4 to 1: 8 dilution was applied to 
peripheral  wells  of macro-Ouchterlony plates  (Fig.  2).  When  injected  intra- 
dermally, 0.1 ml of a  1:6400 to 1:12,800 dilution of untreated filtrate was suffi- 
cient to cause the characteristic delayed, sustained,  erythematous, edematous, 
indurated local reaction in adult rabbits, whereas 2- to 4-fold larger amounts of 
BPL treated filtrates were required to give the same reaction. 
Isolation  of  Choleragen  and  Choleragenoid.--Initially,  choleragen  was  sep- 
arated from the bulk of contaminating material present in the (NH4)2SO4 preci- 
pitate  of  culture  supernate  by  chromatography  on  5  X  50  cm  columns 
of DEAEC.  The dialyzed,  lyophilized precipitate was re.suspended in 0.01 
PO4 buffer, pH 7.5, and applied to the DEAEC column. Elution was carried out 
in a stepwise fashion, employing the initial buffer followed by 0.1 ~  phosphate, 
pH 6.0,  and finally 1.0 ~  NaC1. The fractions were tested for the presence of 
choleragen antigen by the Ouchterlony technique. As shown in Fig. 3a, the bulk 
of the antigen was eluted by the 0.1 M buffer at pH 6 and separate pools, B1, B2, 
and  B3,  were concentrated  by ultrafiltration  and  applied  to  Agarose  A-5m. 
Fractions constituting the peak of antigen activity (Fig. 3b) were again pooled, 
concentrated, and subjected to gel filtration onAgarose A-5m (Fig. 3c). The peak 
of antigen activity was then applied to a column of Sephadex G-75. The latter 
procedure resulted in the partial separation of three protein peaks (Fig. 3d); of 
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method with  anti-choleragen serum.  On  the  basis  of these  observations,  the 
procedure was modified to the batch method of DEAEC adsorption and elution 
described in Materials and Methods; a  larger Agarose column was  employed 
(Fig. 4a) ; and better final separation was achieved by using two Sephadex G-75 
columns connected in series.  The results, (Fig. 4b), indicated the presence of at 
least  two protein peaks.  In  testing immunologic activity of fractions eluting 
from the double G-75 columns by the micro-Ouchterlony technique, it was ob- 
served that the distance from the antigen well to the nearest edge of the precipi- 
tin band followed a diphasic curve (Fig. 4b) corresponding to the diphasic opti- 
cal density profile. The two major protein antigen-containing peaks were pooled 
separately and concentrated by ultrafiltration. Choleragenicity tests in infant 
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FIO.  1.  Choleragenicity  assay  of untreated  and  BPL-treated  fermenter  filtrate. 
rabbits  indicated  that  the  first  peak,  choleragen,  was  extremely  active in 
producing diarrhea in infant rabbits (see below). The second peak, which gave 
strong precipitin  reactions with anti-choleragen serum, was relatively inactive 
in producing cholera in infant rabbits. The latter peak contains the protein we 
have designated as "choleragenoid". 
Estimations of Molecular  Size of Choleragen and Cholerage~oid.--Adaptation 
of the method of Andrews  (13)  permitted an approximation of the molecular 
size of choleragen and  choleragenoid based upon  their elution volumes from 
double  Sephadex  G-75  columns  calibrated  with  known  molecular  weight 
"marker" proteins, bovine serum albumin  (BSA),  ovalbumin, and myoglobin 
(Mann  Research Laboratories,  Inc.,  New York,  N.Y.).  The results  (Fig.  5) 
indicated that choleragen, with an elution volume of 388 ml (Fig. 4b), behaved 
like a  protein of 61,000 mol wt and choleragenoid, elution volume of 446 ml 
(Fig. 4b), like one of 42,000.  The third, inactive smaller component, mol wt  = 
33,000, was not characterized further. These observations have been reproduced 190  PATttOGENESIS  Or  EXPERIMENTAL  CHOLERA 
repeatedly. On the other hand, results derived from Agarose A-5m gel filtration 
on  similarly  calibrated  colunms  have  indicated,  again  repeatedly,  that  these 
molecules behave in  that system as if their mol wt was below 20,000.  On ultra- 
Fro. 2.  Ouchterlony precipitin assay of untreated (upper pattern) and BPL-treated 
fermenter filtrate (lower pattern). Center wells: rabbit anti-choleragen serum; periph- 
eral wells: dilutions  of filtrate as indicated  (U =  undiluted). 
centrifugation in saline (Fig. 6), the sedimentation coefficient of purified choler- 
agen was calculated to be 5.6 S while that of choleragenoid was 4.2 S. Although 
both protdns sedimented as single symmetrical peaks indicative of homogene- 
ous preparations,  the sedimentation coefficients were suggestive of larger molec- 
ular  sizes.  An  attempt  was made  to  resolve  the  enigma  presented  by  these 
apparently  conflicting  observations  by  means  of filtration  with  Diaflo mere- 0 
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FIG. 3.  Isolation  of  choleragen  by  sequential  chromatography  on  columns  of 
DEAEC (A), Agarose  A-Sm (B and C) and Sephadex G-75 (D). A. Stepwise elution, 
with indicated buffers, from 5 ×  50 cm column of DEAEC, 20 ml per fraction. B. Gel 
filtrations of pools,  BI, B2, and B3 (from A), on Agarose  A-Sm, 2.5  X  87 cm, Tris- 
EDTA buffer, flow rate 20 ml/hr, discard first 280 ml, 2 ml per fraction. C. Gel filtra- 
tion of active fractions from B on Agarose A-5m. Conditions similar to B. Interrupted 
dash curve delineates a component with absorption maximum at OD 415. Vertical dash 
lines indicate fractions pooled for further purification. D. Gel filtration of active peak 
(dash lines, C) on Sephadex G-75, 2.5  X  85 cm, 0.4 M ammonium formate, flow rate 
20 ml/hr, discard first 150 ml, 2 ml per fraction. Cross hatched areas under curves in A 
and B represent estimates of relative antigen content by intensity of precipitin band 
observed in Ouchterlony test. 
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branes  of different porosity. The activity,  both  antigenic  and  choleragenic,  of 
crude fermenter culture supernatants,  was found to be fully retained by UN[-10 
and UM-20E membranes rated by the manufacturer to retain proteins of sizes 
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FIG. 4.  Gel filtration of DEAEC eluate of (NH4)2SO4 precipitate from four fermen- 
ter supernates on Agarose A-5m (A) followed by Sephadex G-75 (B). A. Gel filtration 
on Agarose A-Sm, 5 X  125 cm, Tris-EDTA buffer, flow rate 60 ml/hr, discard first 912 
ml, 10 ml per fraction. Fractions to right of vertical dash line pooled for further purifi- 
cation. B. Gel filtration on Sephadex G-75, two 2.5  X  90 cm columns in series,  0.4 M 
ammonium formate buffer, flow rate 20 ml/hr, discard first 242 ml, 2 ml per fraction. 
Dash curves represent distance in mm from antigen well to preeipitin band in micro- 
Ouchterlony test. (In this case, an earlier pattern with 5 mm distances from peripheral 
wells to central wells was used.) 
larger  than  10,000 and  20,000,  respectively. XM-50 membranes,  with  a  cutoff 
stated to be 50,000 tool wt, retained approximately 50 % of the antigen activity. 
However,  gel filtration  studies  of the  XM-50  retentate  indicated  that  it  was 
partially enriched in the larger,  choleragen, moiety whereas  the effluent,  which 
passed  through the XM-50 membrane,  was found to be somewhat enriched in 
the  smaller-sized,  choleragenoid  species.  The  XM-50 membrane,  when  tested RICItARD  A.  FINKELSTEIN  AND  JOSEPH  LOSPALLIYTO  193 
with known protein markers, was found to retain BSA (tool wt =  45,000), but 
allowed passage of chymotrypsinogen (mol wt =  25,000).  Thus, the membrane 
filtration results tend to support the molecular size approximations obtained by 
Sephadex G-75 gel filtration. Apparently, the moieties behaved anomalously on 
Agarose A-5m and studies are in progress to determine whether reversible aggre- 
gation and disaggregation takes place. 
Radial Diffusion Immunoassay of Choleragen and Choleragenoid.--The radial 
diffusion immunoassay technique was found to be a sensitive, precise, and re- 
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FIG. 5.  Molecular size estimation of choleragen and choleragenoid by gel filtration 
on Sephadex G-75 double columns in comparison with known molecular weight marker 
proteins. 
producible method of detecting and quantitating choleragen and choleragenoid. 
Patterns resulting from a typical assay are depicted in Fig. 7 and zone diameters 
resulting from assays of a choleragen and choleragenoid preparation performed 
in quadruplicate, are summarized in Table I. The relationship between concen- 
tration of antigen,  plotted logarithmically, and precipitin ring  diameter was 
linear over greater than a 4-fold range of concentrations, as illustrated in Fig. 8. 
Statistical analysis did not reveal the regression curves to differ significantly 
although  results  practically  identical  to  these  were  obtained  with  different 
choleragen and choleragenoid preparations assayed on different occasions. As 
might be expected from its smaller molecular size, choleragenoid produced larger 
zone diameters than choleragen at the same concentration. 
Immunoelectrophoresis of  Choleragen and  Choleragenoid.--Immunoelectro- FIG. 6.  Ultracentrifugation of choleragen (upper pattern) and choleragenoid (lower 
pattern)  in  double  sector  cell.  Choleragen,  4.4  mg/ml;  choleragenoid,  9.0  rag/ 
ml; 39,460 rpm; 116 rain, elapsed time. 
FIG. 7.  Radial diffusion immune precipitation of choleragen. Top row, 1.  to r., 20, 
30, 40, 50, 75,  100 #g choleragen per ml. Bottom row, same concentrations, r. to 1.4 ~1 
per well. 
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phoretic analysis of choleragen, choleragenoid, and artificial mixtures of the two 
isolated components (Fig. 9) revealed that choleragen migrated faster than did 
choleragenoid. In mixture, the two formed a continuous precipitin band with the 
anti-choleragen serum. Similar tests with unadsorbed sera gave identical results: 
there was no evidence of other components reactive with serum prepared against 
crude choleragen or live vibrios. It should also be mentioned that older prepara- 
tions of partially purified choleragen gave a pattern identical with that of the 
artificial mixture of the two components. Neither BPL nor (NH4)2S04 had been 
used in their preparation. 
Antigenic Identity of Choleragen and Choleragenoid.--Macro-Ouchterlony tests 
TABLE  I 
RADIAL  DIFFUSION  IMMUNOASSAY OF CHOLERAGEN AND "CHOLERAGENOID" 
CHOLERAGEN 
ANTIGENcoNc.,  I  ZONE DIAMETER (rnm.) 
/lg./ml.  1  2  3  4  Mean ± 2 s 
20.0  4.83  4.92  4.98  4.83  4.89 -+ 0.14 
40.0  6.18  6.18  6.03  6.03  6,11-+017 
60.6  7.20  7.20  7.23  7.41  7.26 _+ 0.20 
81.0  8.25  8.10  7.89  8.25  8.12-+0.34 
CHOLERAGENOID 
ANTIGEN  [  ZONE DIAMETER[(mm.) 
CONC.*  1  2  3  4  Mean ± 2 s 
/lg./ml. 
10.0  4.0S  3.99  3.90  3.78  3.93 + 0.23 
14.7  4.77  4.65  4.68  4.71  4.70 _+ 0.32 
20.0  5.70  5.43  5.52  5.28  5.48 _+ 0.37 
30.1  6.60  6.18  6.30  6.15  6.31 _+ 0.22 
*Note.:  Since  volumes  of 4~. were used in making these  determinations,  the actual  amount of 
antigen  is given by multiplying the concentration  by 0.004.  Thus the system  detects 
amounts of antigen of the order of 4 x  10  -8 g. 
(Fig. 10) also showed the two components to be immunologically identical,  at 
least by their reaction with our standard antiserum. Because of the possibility 
that the standard antiserum, which was prepared against what now appears to 
be a mixture of the two components, might have been directed primarily against 
the choleragenoid component, it was conceivable that the antiserum could not 
detect antigens unique to the larger, more highly charged, choleragen. For this 
reason, additional antisera were prepared in rabbits, against each of the isolated 
components.  Each  antiserum  gave  reactions  of complete cross-identity with 
both choleragen and choleragenoid. In addition each of the antisera gave only a 
single precipitin line when tested against crude culture filtrate (except for the 
serum of 1 of 4 rabbits immunized with choleragenoid). The exception, which 
produced only a single band when tested with isolated choleragen and choler- 
agenoid, gave a second minor band when tested with crude cholera culture fil- 
trate.  In contrast to previous experience (11), none of the antisera gave any 
evidence of agglutinating  antibody when  tested  against  live antigens  of the 196  PATHOGENESIS  OF  EXPERIMENTAL  CHOLERA 
homologous culture. Rises of vibriocidal antibody activity of the sara tested by 
an exquisitely sensitive technique (16)  were inconsequential. Some of the im- 
munized rabbit sara exhibited transient rises to titers as high as 102 (two tubes) 
declining to 101 by 4 wk postinoculation while the precipitin titer continued to 
rise. Others failed to show any rises. 
Electrophoresis of ChoIeragen and Choleragenoid.--Choleragen  was found to 
give a  single, broad,  protein-staining band after electrophoretic separation in 
polyacrilamide gel. This was in marked contrast with previous experience (5) in 
which partially purified material was found to contain multiple protein-staining 
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Fro. 8.  Least squares regression lines relating antigen concentration to precipitin 
ring diameter for choleragen and choleragenoid. 
constituents.  Choleragenoid,  on  the  other  hand,  exhibited  four  or five very 
closely spaced bands which had migrated further than the choleragen band (Fig. 
11). 
Protein Determinations  on Choleragen and Choleragenoid.--Repeated  protein 
determinations, by the biuret technique, on lyophilized preparations of choler- 
agen and choleragenoid indicated protein contents between 85-92 %. No carbo- 
hydrate could be detected by periodic acid-Schiff staining  after disc  electro- 
phoresis. No lipid could be detected when the proteins were each extracted with 
3:1  CHC13-methanol and the extracts applied to thin layer plates containing 
Dichlorofluorescein. The technique was sufficiently sensitive to recognize lipid 
contamination at the 1% level. 
Biological Activity of Choleragen and Choleragenoid.--Tests  in infant rabbits of 
isolated choleragen indicated that a mean choleragenic score of 5 was produced 
by doses of different preparations ranging between 0.25  and 0.5 #g. Approxi- RICHARD A.  FINKELSTEIN AND  JOSEPH LoSPALLUTO  197 
FIG. 9.  Immunoelectrophoresis of choleragen, choleragenoid, and an artificial mix- 
ture of the two. Top slide: choleragen  (upper well)  and choleragenoid  (lower  well). 
Middle slide: artificial mixture (upper well) and choleragen (lower well).  Lower slide: 
artificial mixture (upper well) and choleragenoid (lower well). FIG.  10.  Ouchterlony precipitin patterns of choleragen and choleragenoid. Cholera- 
gen (upper right and lower left); choleragenoid  (upper left and lower right); approxi- 
mately 100 #g per well; side wells are empty. 
Fro.  11.  Polyacrilamide  gel  (disc)  electrophoresis of choleragen  (left)  and  choler- 
agenoid (right). 
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mately 50 #g or more of choleragenoid was required to produce the same effect. 
Choleragen in doses as small as 0.0004/zg produced typical reactions in rabbit 
skin;  the minimal  skin  test dose of choleragenoid ranged between 0.015  and 
0.125  #g. Preliminary tests using the ligated rabbit intestinal loop assay have 
indicated that amounts of choleragen less than 1/~g are sufficient to produce a 
positive reaction. 
DISCUSSION 
The results presented above indicate that choleragen may be obtained in a 
relatively high state of purity and high specific activity by the procedures de- 
scribed. The procedure also entails considerable losses,  in part attributable to 
our discarding of active fractions which have relatively high levels of unrelated 
proteins for the sake of ultimate purification, and possibly in part to inactiva- 
tion and losses inherent in the procedures. Preliminary observations indicate 
that these losses may largely be circumvented by using selective ultrafiltration 
steps in lieu of the (NH4)2SO~ precipitation and DEAEC absorption and elution. 
The isolated protein appears to be homogeneous by all available criteria (im- 
munoelectrophoresis,  disc  electrophoresis,  ultracentrifugation,  and  immuno- 
logic) and behaves as a pure, unconjugated protein, with molecular size of 61,000 
determined by Sephadex gel filtration and supported by membrane filtration 
experiments. The apparent peculiarity of its retention on Agarose A-Sm was 
most useful in its isolation since, by Agarose gel filtration, it was effectively 
separated from unrelated proteins, which presumably behave normally in that 
system, and would otherwise accompany choleragen isolated only by Sephadex 
gel filtration. The sedimentation coefficient of purified material was higher than 
one would expect suggesting that  aggregation may occur in normal saline or 
other low molarity solutions. It is of interest that the sedimentation coefficient 
corresponded more closely with  previous estimates  of size  (5)  obtained with 
impure material isolated by other techniques. 
In a recent report, Coleman et al (17) claim to have purified a cholera entero- 
toxin, the so-called "ileal loop reactive type 2 toxin" of Burrows (18), from cell 
lysates and from peptone broth cultures. We have found both of these to be rela- 
tively poor sources of choleragen (5, and unpublished studies). Although their 
product was derived from the same vibrio strain, its reported properties are so 
different from those observed in our studies that  the question is raised as to 
whether it is the same substance. If their ileal loop reactive toxin is choleragen, 
then the high lipid content and relatively low specific activity of their product 
(approximately l/~ o of that reported herein) would suggest over 90 % contamina- 
tion with unrelated materials. The authors indicated that, for preparative pur- 
poses,  their  "fraction I" was  eluted directly from DEAE-Sephadex with de- 
ionized water without preliminary or subsequent  treatment.  That being the 
case, our observations (Fig. 3a-d) would suggest that an extremely impure prod- 200  PATHOGENESIS  OF  EXPERIMENTAL  CHOLERA 
uct would  result and this factor could explain some of the discrepancies in the 
two studies. The authors did acknowledge the possibility that toxicity might 
reside in a component of "the fraction I complex". 
The finding of an antigenically identical moiety, choleragenoid, which seems 
to be devoid of choleragenic or skin-reactive activity, (the low levels of specific 
biologic  activity found in  our  choleragenoid preparations  could  readily and 
likely be attributable to a  1% contamination with choleragen which precedes 
the choleragenoid in eluting from the Sephadex G-75 columns) is of considerable 
interest from both the standpoint of its relationship to choleragen and its poten- 
tial value as a nontoxic immunogen. Our studies have provided no information 
as to whether it is a precursor to, or a degradation product of, choleragen. The 
choleragen molecule is apparently larger and more highly charged and one might 
speculate that  in  these differences lies the  faculty of causing the  diarrhea  of 
cholera. It is also of interest that, even with its larger size and different charge, 
the choleragen moiety gains no antigenic feature to distinguish it from choler- 
agenoid. It should be pointed out that choleragenoid does not appear to be an 
artifact of the isolation procedure since both moieties have been isolated from 
culture filtrates not treated with BPL and subjected to only gentle separation 
by physical methods involving only Diaflo and gel filtration (to be published, 
present authors). 
Both moieties are antigenic. If choleragenoid is a precursor of choleragen, it 
might be possible to isolate a stable mutant, which one might predict would be 
incapable of causing cholera, and which could potentially provide the ideal im- 
munizing  agent--a  living,  attenuated  vibrio, capable of multiplication in the 
gut and stimulation of both antibacterial and antitoxic immunity at the impor- 
tant local level. 
Of paramount interest with regard to the pathogenic mechanism of cholera is 
the observation that apparently pure choleragen in minute amount retains the 
capacity to  produce  alterations  of  permeability of  vascular  endothelium  as 
demonstrated in the skin test. Thus, it now seems more likely that choleragenic- 
ity and increased vascular permeability are intimately associated phenomena. 
This does not prove that the diarrhea of cholera is the result of increased vascular 
permeability. Rather,  the  observations make it more probable that  the  same 
basic  biochemical-physiological  lesion,  initiated  by  this  single  substance,  may  be 
"expressed"  as an  alteration  of vascular permeability  in skin  or an outpouring  of 
fluid in gut, and suggest the potential value of experimental inquiry into a com- 
mon mechanism. 
The  availability  of  purified  components  should  facilitate  more  definitive 
studies on the chemical composition and nature of choleragen, its mode of ac- 
tion, and its potential role in the production of immunity. Additional observa- 
tions on biologic activities of choleragen were summarized recently (19). RICHARD A.  ~INKELSTEIN AND JOSEPH LoSPALLUTO  201 
SUMMARy 
Choleragen, a diarrheagenic protein enterotoxin elaborated by Vibrio choleras, 
has been isolated from the supernate of fermenter cultures by steps involving 
ammonium sulfate precipitation, DEAE cellulose, Sephadex G-75, and Agarose 
A-Sin chromatography. The resulting product appears to be pure according to 
immunoelectrophorefic, disc electrophoretic, ultracentrifugal, and {mmunologic 
criteria. Sephadex gel filtration and membrane filtration studies suggest a molec- 
ular size of 61,000. The isolated product is highly active in inducing experi- 
mental cholera in infant and adult rabbit models. It also elicits, in small dosage, 
an increased vascular permeability in skin. These observations indicate that 
choleragenicity and increased vascular permeability are intimately associated 
phenomena and may be manifestations of the same basic mechanism. 
An additional, antigenically identical, protein has also been isolated by the 
same procedures. The latter substance, termed "choleragenoid", lacks the per- 
meability effect and choleragenicity of the choleragen moiety. Its size (estimated 
from Sephadex gel filtration at 42,000) is smaller than that of choleragen and it 
also differs in charge. Choleragenoid may prove useful as a nontoxic immunogen 
to protect against pathologic effects of V. cholerae infection. 
Miss Julia Balfour, Miss Barbara Smith, and Mrs. Lee Pelley furnished able technical 
assistance during portions of the study. We are grateful to Dr. Elvin A. Kabat for reviewing 
the manuscript. 
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